[1]
A. Halder, V. Burade, A. J. Khopade, and A. Thavkar, “Efficacy and safety of bimatoprost 0.01% formulated in tight junction modulation technology compared to marketed benzalkonium chloride preserved bimatoprost 0.01% ophthalmic solution in healthy beagle dogs”, Int J Basic Clin Pharmacol, vol. 9, no. 8, pp. 1210–1216, Jul. 2020.